Clinical Trial: Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting

Brief Summary: This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.

Detailed Summary:
Sponsor: Novartis Pharmaceuticals

Current Primary Outcome:

• Serum Creatinine and liver enzyme levels [ Time Frame: 3 years ]
  Observed over 3 years for each patient
• Adverse Drug Reactions [ Time Frame: 3 years ]
  Observed over 3 years for each patient

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Novartis

Dates:
Date Received: July 12, 2011
Date Started: July 2011
Date Completion:
Last Updated: February 1, 2016
Last Verified: February 2016